INTRODUCTION AND OBJECTIVES:
To compare first generation high-frequency 29 MHz transrectal micro-ultrasound (micro-US) with conventional low-frequency 7-12 MHz transrectal ultrasound (conv-US) for the detection of clinically-significant prostate cancer (csPCA).
METHODS: 1,676 men indicated for prostate biopsy and without known prostate cancer were randomized 1:1 to micro-US or conv-US guided biopsy at 5 sites in North America from 2013-16. Exactly 12-cores were taken transrectally from each subject, with each core taken either systematically or from a target near the systematic position. The trial was paused after 1,113 subjects to train investigators on the new PRI-MUS TM (Prostate Risk Identification using Micro-Ultrasound) protocol for micro-US targeting, developed using data from the first portion of the trial. csPCA was defined as any Gleason Grade Group > 1 and/or any core with > 50% cancer.
RESULTS: The per-patient detection rates of csPCA in the intent-to-treat (ITT) analysis did not differ between transrectal micro-US and conv-US arms (34.6% (290/837) vs. 36.6% (307/839), respectively, p[0.21). However, the per-protocol analysis (PP) detection rate of csPCA was significantly greater with micro-US (43.7% (125/286) vs. 36.6% (301/823), p[0.02). After PRI-MUS training, sensitivity improved to 63.4% from 24.7% for micro-US (p<0.01), but at the cost of lower specificity (post-training for micro-US [ 61.7%, conv-US [ 89.5%), suggesting a learning curve to micro-US interpretation across all investigators. Unexpected prostate under-sampling was noted in the micro-US arm, where 65.8% of men had inadequate sampling of the prostatic apex, which explains the disparity in number of subjects between the ITT and PP groups.
CONCLUSIONS: First generation transrectal micro-US with PRI-MUS achieved greater sensitivity to detect significant prostate cancers than conventional TRUS. Despite limitations of the firstgeneration instrument, when clinicians were instructed in micro-US image interpretation and used proper systematic biopsy technique with the experimental probe, greater cancer detection rates were achieved with the same number of biopsy samples. This work also represents the first prospective validation of a protocol for real-time lesion identification and biopsy targeting using micro-US (PRI-MUS).
Additional studies are underway to refine use and application of this novel imaging technology.
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INTRODUCTION AND OBJECTIVES: Non-contrast computed tomography (NCCT) is the imaging modality of choice in evaluating patients with urolithiasis. In the absence of hydronephrosis or a delayed contrast phase, delineation of the collecting system is not possible. Thus, the surgical plan may not be fully devised until a retrograde pyelogram is performed at the time of surgery. The combination of hydration and furosemide has been shown to improve visualization of the upper urinary tract during contrast-enhanced CT imaging. We evaluated the effect of the DRINK protocol (pre-imaging oral hydration and a single oral dose of furosemide) on delineation of the collecting system during NCCT.
METHODS: In this prospective, non-randomized study, each participant's pre-existing NCCT scan served as a control. For the study NCCT, each patient was instructed to drink one liter of water and take 20 mg of oral furosemide within the hour prior to their study. A distension score was given for three segments (upper, middle, and lower infundibula) in the axial, coronal, and sagittal views of the nonaffected kidney. Scores (0-3) were based on the percentage of the segment that was distended compared to the prior non-DRINK NCCT (0[0%; 1[<50%; 2[50-99%; 3[100%). Images were scored by a radiologist and two fellowship trained endourologists. Distension scores for both the control and DRINK hydration protocol were compared. The nonparametric Wilcoxon signed-rank test was used to test for statistical change. RESULTS: Among 15 study patients, collecting system distension scores were significantly higher after the hydration and lasix protocol when compared to the images from their past non-DRINK NCCT scans (p<0.05) ( Table 1 ). This pattern of statistically significant change extended across all image views (axial, coronal, and sagittal) and all infundibula (upper, middle, and lower).
CONCLUSIONS: Hydration and furosemide given an hour prior to NCCT (i.e. DRINK protocol) result in a measurably increased distension of the collecting system.
INTRODUCTION AND OBJECTIVES:
Most recent AUA guidelines suggest that an expected drop of estimated glomerular filtration rate (eGFR) below 45 ml/min/1.733 upon radical nephrectomy (RN) should guide decision-making between RN and partial nephrectomy (PN) in patients with anatomically complex tumors. However, limited clinical tools are available to help with this assessment. Here, we examine the correlation between nuclear renal scan (NRS) -measured split renal function (nSRF) and renal parenchyma anatomic-measured (volumetric-estimated) split renal function (aSRF) in patients who underwent RN. We further assess the predictive value of nSRF and aSRF in anticipating post-operative eGFR decline after RN.
METHODS: From our prospectively-maintained renal database, we identified patients with an enhancing renal mass who had both NRS and multiphase CT performed prior to RN. The average of three varying formulations for calculated renal parenchymal volumes was utilized. aSRF was determined by the ratio of the residual volume (parenchymal volume minus tumor volume) of the diseased kidney to the anatomic-measured total volume of both kidneys. Relationship of the ratio of aSRF to nSRF was examined at increasing tumor sizes to assess for over-estimation or under-estimation of SRF based on the calculated r-value. Spearman correlation coefficients were obtained between decline in eGFR and nSRF/aSRF. RESULTS: 37 patients were identified meeting criteria (median age 59 yrs , median pre-operative eGFR 73.83 ml/min/1.733 ml/min/1.733]). Median maximum tumor diameter was 3.7 cm (IQR 1.7-4.6 cm) and median numerical RENAL nephrometry score was 10 (IQR 8-11). There was a significant and negative correlation with increasing tumor size to the ratio of aSRF to nSRF (r [ -0.58, p [ 0.0005) (Figure 1 ). Median post-RN change in eGFR was -23.66 ml/min/1.733 
